z-logo
open-access-imgOpen Access
GnRH antagonist-induced inhibition of the premature LH surge increases pregnancy rates in IUI-stimulated cycles. A prospective randomized trial
Author(s) -
Adolfo Allegra,
Angelo Marino,
Francesco Coffaro,
P Scaglione,
Francesca Sammartano,
Giovanni Manca Rizza,
Aldo Volpes
Publication year - 2006
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/del337
Subject(s) - pregnancy rate , antagonist , group b , medicine , pregnancy , randomized controlled trial , insemination , intrauterine insemination , randomization , artificial insemination , gonadotropin , gonadotropin releasing hormone antagonist , andrology , gynecology , endocrinology , gonadotropin releasing hormone , luteinizing hormone , biology , hormone , receptor , genetics , sperm
Our prospective randomized controlled trial was designed to assess whether the use of GnRH antagonists can improve the success rate of controlled ovarian stimulation (COS)/intrauterine insemination (IUI) treatments, via inhibition of the premature LH rise.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom